INS and serum lipopolysaccharide activity: Enhances gut barrier function, reduces liver inflammation, decreases proinflammatory markers like TNF-α and IL-6, modulates bile acid metabolism, decreases endotoxemia, increases mucin production, reduces oxidative stress, influences Kupffer cells, produces antimicrobial substances.Modulates SREBP activity, influences hepatic lipid metabolism, enhances insulin sensitivity.